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Porcine kobuvirus was ﬁ  rst identiﬁ  ed in early 2007 in 
Hungary. Originally thought to be conﬁ  ned to the intestine, 
almost 2 years later the virus was found in the blood of clini-
cally healthy pigs on the same farm. Porcine kobuvirus may 
be widely distributed on pig farms worldwide.
P
icornaviruses (family Picornaviridae) are small, non-
enveloped viruses with single-stranded, positive-sense 
genomic RNA; they are divided into 12 genera: Aphthovi-
rus, Avihepatovirus, Cardiovirus, Enterovirus, Erbovirus, 
Hepatovirus, Parechovirus, Sapelovirus, Senecavirus, Tes-
chovirus, Tremovirus, and Kobuvirus (1). The genus Kobu-
virus consists of 2 ofﬁ  cially recognized species, Aichi virus 
and  Bovine kobuvirus, and 1 candidate species, porcine 
kobuvirus (2–4). Aichi virus (strain A846/88) was ﬁ  rst iso-
lated in 1989 in Japan, from a fecal sample from a person 
with acute gastroenteritis (2). Aichi viruses have also been 
detected in human fecal samples in other countries in Asia 
(5); Europe (6,7), including Hungary; South America (6); 
and North Africa (8). Bovine kobuvirus (strain U-1) has 
been detected in culture medium derived from cattle serum 
suspected to be contaminated with cattle feces (3) and in 
fecal samples from cattle in 2003 in Japan (3) and in 2008 
in Thailand (9) and Hungary (10). 
Porcine kobuvirus was ﬁ  rst identiﬁ  ed and the com-
plete genome (S-1-HUN; EU787450) characterized from 
fecal samples from domestic pigs in Hungary (4,11). Por-
cine kobuvirus has also been recently (2009) reported from 
the People’s Republic of China (12). Kobuvirus genomes 
are ≈8.2–8.4 kb. Genome organization includes leader (L) 
protein following structural (VP0, VP3, and VP1) and non-
structural (2A-2C and 3A-3D) regions (1,3,4,11). Genetic 
identity on the coding region between Aichi, U-1, and S-1-
HUN viruses varies from 35% (L protein) to 74% (3D re-
gion) (3,11). 
Kobuvirus infection has been thought to be conﬁ  ned 
to the intestine. To our knowledge, detection of kobuvirus 
in the infected host species serum (viremia) has not been 
reported. We report the endemic circulation and in vivo 
evolution of porcine kobuvirus on a pig farm where the 
virus was originally discovered and virus escape from the 
gastrointestinal tract, resulting in viremia in domestic pigs.
The Study
In February 2007, a total of 39 (65%) of 60 fecal 
samples from clinically healthy domestic pigs on a farm in 
eastern Hungary were positive (by reverse transcription–
PCR) for porcine kobuvirus (11) (Table 1). In November 
2008, 21 months later, we obtained 60 fecal and 60 serum 
sample pairs, again from apparently clinically healthy do-
mestic pigs on the same farm. We divided these pigs, all <6 
months of age with no diarrhea, into 4 age groups (Table 
1). Blood samples were taken from the jugular vein by us-
ing closed vacuum sets. Fecal and serum samples were 
processed and tested separately for porcine kobuvirus by 
using the same methods (RNA isolation, reverse transcrip-
tion–PCR) and the same primers for screening (UNIV-ko-
bu-F/UNIV-kobu-R for 3D) and for the complete genome 
analysis  described previously (11). PCR products were 
sequenced directly in both directions with the BigDye Re-
action Kit (Applied Biosystems, Warrington, UK) by using 
the PCR primers and an automated sequencer (ABI PRISM 
310 Genetic Analyzer; Applied Biosystems, Stafford, TX, 
USA). The genome was assigned GenBank accession no. 
GQ249161. Kobuvirus-positive fecal samples were inocu-
lated into Vero cells. 
Porcine kobuvirus RNA was detected in 32 (53.3%) 
of the 60 fecal samples and 16 (26.6%) of the 60 serum 
samples collected in November 2008 (Table 1). Porcine 
kobuvirus was found in at least 1 fecal sample from each 
age group; from serum samples, viral RNA was detected in 
1 sample from the 10-day group, 7 samples from the 3–4-
week group, and 8 samples from the 6-month group. Por-
cine kobuvirus was identiﬁ  ed in 9 sample pairs (feces and 
serum) collected at the same time. Only the serum or fecal 
samples were kobuvirus positive, for 7 and 23 animals, re-
spectively. The 173-nt sequences of kobuvirus 3D region 
were genetically identical in all serum and fecal samples 
collected in 2007 and 2008. 
The complete genetic sequence of strain kobuvirus/
swine/K-30-HUN/2008/Hungary, detected in a fecal speci-
men from a 3–4-week-old pig in 2008, was determined and 
compared with the prototype strain kobuvirus/swine/S-1-
HUN/2007/Hungary (Table 2). In the nonstructural 2A-3D 
regions, 74 (1.7%; 1.14%–2.43% between 3D and 3C) nu-
cleotide substitutions could be detected between the proto-
type strains collected in 2007 (S-1-HUN) and 2008 (K-30-
HUN), which led to 13 (0.9%) nonsynonymous amino acid 
changes (2, 2, 5, 2, and 2 aa in the 2A, 2B, 2C, 3C, and 3D 
regions). In structural regions, 36 (1.42%) nt substitutions 
were detected, leading to 6 (0.71%) nonsynonymous amino 
acid changes (3–3 aa in VP0 and VP3 regions). The highest 
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and the lowest rates of nucleotide mutations were seen in 
coding regions, L and 3D, respectively (Table 2). For ami-
no acid levels, the highest changes in percentage within the 
21-month period were found in 2C (1.49%), 2A (1.47%), 
and VP3 (1.34%) (Table 2). No amino acid changes were 
detected in regions VP1, 3A, and 3B. No cytopathic effect 
was seen in Vero cells after serial passages.
Conclusions
We report the endemic circulation and natural inter-
host evolution of porcine kobuvirus among domestic pigs 
on a pig farm within a 21-month period. This follow-up 
study indicates that domestic pigs are generally infected 
with porcine kobuvirus. It is likely that porcine kobuvirus 
is not restricted geographically and is widely distributed on 
pig farms worldwide. According to a veterinarian’s clinical 
report, no clinical signs were associated with the endemic 
kobuvirus infection. In this closed-animal community, the 
susceptible young host generations were continuously in-
fected; the length of the cycle interval when the virus is out-
side the host (nonreplicative viral form) is probably short. 
However, the number of nucleotide changes is consistent 
with rates observed for other picornaviruses (13–15), sug-
gesting good adaptation of the virus–host relationship. This 
adaptation is also supported by the level of the nucleotide 
changes in different gene regions. More nucleotide muta-
tions were found in nonstructural than in structural regions, 
which leads to a nearly equal probability for nonsynony-
mous amino acid changes in these 2 regions. 
No available data conﬁ  rm transmission mode, trans-
mission efﬁ  ciency, and pathogenesis of kobuviruses. Aichi 
virus has been reported to be shed in feces and maybe trans-
mitted by food (especially seafood) in humans (2,5,7), sug-
gesting fecal–oral transmission. However, in the pigs, viral 
RNA or infectious kobuvirus particles were also present 
in serum of virus-infected pigs. This ﬁ  nding suggests that 
porcine kobuvirus (and possibly kobuviruses in general) 
escaped the gastrointestinal tract into the circulatory sys-
tem in immunocompetent virus-infected hosts, resulting in 
viremia. Further study is needed to investigate whether the 
viremia was acquired passively or actively. In addition to 
direct fecal–oral transmission, the possibility of kobuvirus 
transmission through breast-feeding (milk) and of blood-
borne, foodborne, and zoonotic infections remains.
Similar explanations for the pathogenesis of many pi-
cornaviruses exist. Escape from the gastrointestinal tract 
into the bloodstream was probably the situation for the bo-
vine kobuvirus detected in culture medium supplemented 
with cattle serum (3), which was suspected of possibly 
being contaminated with feces containing bovine kobuvi-
ruses. Porcine kobuvirus viremia open these data to another 
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Table 2. Natural interhost in vivo mutation changes in sequences of 2 porcine kobuvirus strains, Hungary* 
Region 
Nucleotides Amino  acids 
Length   Difference  % Difference  Length  Difference  % Difference 
5ƍ  UTR  576  1  0.17  –  –  – 
L 585  15  2.56  195  1  0.51 
VP0 1,098  19  1.73  366  3  0.82 
VP3 669  8  1.19  223  3  1.34 
VP1 762  9  1.18  254  0  0 
2A 408  6  1.47  136  2  1.47 
2B 585  7  1.19  195  2  1.02 
2C 1,005  23  2.28  335  5  1.49 
3A 270  6  2.22  90  0  0 
3B 102  2  1.96  34  0  0 
3C 576  14  2.43  192  2  1.04 
3D 1,407  16  1.14  469  2  0.42 
3ƍ  UTR  167  1  0.6  –  –  – 
Nonstructural† 4,353  74  1.7 1,451 13  0.89 
Structural‡  2,529 36  1.42  843  6  0.71 
Complete genome  8,210  127  1.54  2,489  20  0.80 
*Strain length shown is for kobuvirus/swine/K-30-HUN/2008/Hungary (accession no. GQ249161) and is compared with prototype strain 
kobuvirus/swine/S-1-HUN/2007/Hungary (length not shown; accession no. EU787450), from samples collected from pigs on the same farm, November 
2008 and February 2007 respectively. UTR, untranslated region; L, leader region. 
†2A-3D. 
‡VP0–VP1. 
Table 1. Incidence of porcine kobuvirus RNA in samples from 
domestic pigs, Hungary*  
Pig age
Specimen, by date 
2007 Feb  2008 Nov 
Feces Feces  Serum 
<10 d  15 (100)  8 (53.3)  1 (6.7) 
<3–4 wk  14 (93.3)  13 (86.7)  7 (46.7) 
<3 mo  3 (20)  5 (33.3)  0
<6 mo  7 (46.7)  6 (40)  8 (53.3) 
Total 39/60 (65)  32/60 (53.3)  16/60 (26.6) 
*Values are no. (%) or no. positive/no. tested (%). All animals were on the 
same farm. For each type of sample and age group, 15 specimens were 
tested. In November 2008, specimens (feces and serum) were collected  
in pairs from the same animals. interpretation for bovine kobuvirus infections and for Aichi 
virus pathogenesis in humans. Aichi virus was identiﬁ  ed 
in low incidence in fecal samples from humans with gas-
troenteritis, but seroprevalence was high (6,7). Knowledge 
about viremia and natural virus evolution is crucial for un-
derstanding the pathogenesis, transmission, immunology, 
and clinical manifestations of kobuvirus infection in gen-
eral and especially in humans.
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